Research and clinical trials for acute myeloid leukaemia (AML)
All treatments must be fully researched before they can be adopted as standard treatment for everyone. This is so that we can be sure they work better than the treatments we already use and so we know that they are safe.
Researchers are looking into better ways to treat AML. This includes looking at:
- reducing the number of side effects
- how treatment affects quality of life
- ways to prevent AML from coming back
- treatment for people whose AML won't go away (refractory) or comes back after treatment (relapsed)
Talk to your specialist if there are any clinical trials that you think you might be able to take part in.
Research into acute myeloid leukaemia (AML)
Here is a summary of some of the research and clinical trials looking into acute myeloid leukaemia (AML).
Find a clinical trial
Our clinical trials database has open, closed and result summaries of trials in the UK.
What clinical trials are
Trials aim to find out if a new treatment or procedure is safe or better than a current treatment.
What you should know before
Find out about what researchers should tell you before you agree to take part in a trial.
Our Research
Find out how our researchers are discovering new ways to tackle leukaemia.
